Epigenetic therapeutics is fastest growing segment fueling the growth of Netherlands Compounding Pharmacies Market
Epigenetic therapeutics is fastest growing segment fueling the growth of Netherlands Compounding Pharmacies Market
Compounding pharmacies prepare customized medications tailor-made to patient's needs. They re-purpose FDA-approved ingredients into

The global Netherlands Compounding Pharmacies Market is estimated to be valued at US$ 520.5 Mn in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Compounding pharmacies prepare customized medications tailor-made to patient's needs. They re-purpose FDA-approved ingredients into medications in alternative formulations like creams, gels, or liquids when commercial products are not suitable. This increases treatment options and adherence.

Market key trends:
One of the key trends in the Netherlands Compounding Pharmacies Market is the rise in demand for personalized medications. With growing awareness about tailored treatment options, there is increasing demand for medications compounded to suit an individual's unique needs like allergies, ability to swallow pills, or other considerations. This is driving more pharmacies to offer compounding services and is fueling the market growth.
Segment Analysis

The Netherlands compounding pharmacies market is segmented by dosage form into capsules, tablets, topical preparations, oral solutions and suspensions, and others. Among these, the topical preparations segment holds the largest share of the market and is expected to remain the dominant segment over the forecast period. This is attributed to the growing demand for topical medications like creams, gels, and ointments to treat skin problems like acne, eczema, and other dermatological conditions prevalent in the country.

Key Takeaways

The global Netherlands Compounding Pharmacies Market Share  is expected to witness high growth, exhibiting CAGR of 8.5% over the forecast period, due to increasing prevalence of chronic conditions like cardiovascular diseases, diabetes, cancer, and neurological disorders in the country.

Regional analysis
The market in North Holland region currently dominates the Netherlands compounding pharmacies market and is expected to maintain its lead over the forecast period. This can be attributed to the presence of major pharmaceutical companies in cities like Amsterdam and Alkmaar. However, the South Holland region is anticipated to witness the fastest growth over the next few years owing to increasing healthcare investments and expanding healthcare infrastructure in major cities like Rotterdam and The Hague.

Key players
Key players operating in the Netherlands compounding pharmacies market include Apotheek Zur Rose, Viataal, Stichting De Apothekerscoöperatie, and Holland Pharma. Apotheek Zur Rose holds the largest share of over 15% in the market and offers a wide range of customized medications through its online platform and brick-and-mortar stores across major cities.

 

For more insights, Read- https://www.ukwebwire.com/netherlands-compounding-pharmacies-market-trends-size-and-share-analysis/

disclaimer

What's your reaction?

Comments

https://www.timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations